Trials / Completed
CompletedNCT03032770
Early Prediction of Placenta Accreta by Ultrasound and Color Doppler
Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 148 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | two-dimensional ultrasound and color Doppler | the eligible participants will be searched for signs suggestive of placenta accreta; low implantation of the gestational sac (\<4cm from the external os), presence of placental lakes, Disruption of placental-myometrial interface and trophoblast overlapping a uterine scar by 2 dimensional transvaginal ultrasound and Intraplacental dilated vessels, turbulent blood flows and greatly increased periplacental vascularity by Doppler ultrasound by level II sonographer and co-investigator under his supervision using ultrasound device. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-12-31
- Completion
- 2020-03-31
- First posted
- 2017-01-26
- Last updated
- 2020-05-13
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03032770. Inclusion in this directory is not an endorsement.